Apogee Enterprises Stock News

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest

Apogee's (APOG) Q4 results gain from solid growth in the Architectural Framing Systems and Architectural Glass businesses, as well as pricing actions.

Apogee Enterprises, Inc. (NASDAQ:APOG ) Q4 2023 Earnings Conference Call April 12, 2023 9:00 AM ET Company Participants Jeff Huebschen - Vice President, Investor Relations & Communications Ty Silberho

Apogee Enterprises (NASDAQ:APOG) has wrapped up its 2023 financial year with fourth-quarter earnings that beat expectations.  The Minneapolis-based provider of architectural products and services fo

Apogee Enterprises (APOG) came out with quarterly earnings of $0.86 per share, beating the Zacks Consensus Estimate of $0.83 per share. This compares to earnings of $0.91 per share a year ago.

Apogee (APOG) gains from solid performance of its Architectural Services and Framing Systems segments, and strategic actions.

Apogee Enterprises continues to post attractive sales, profit, and cash flow growth. It's unclear what the picture holds for the business, but the overall picture looks positive for shareholders at th

A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends.

There is a slew of dividend increases coming in February, including from dividend kings Genuine Parts, 3M, and PepsiCo in the first half of the month. Other popular stocks that traditionally announce

A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends.

Franco-Nevada Corporation (FNV), Mercantile Bank Corporation (MBWM), Apogee Enterprises (APOG) and First Busey Corporation (BUSE) recently hiked dividends.

A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends.

Estimate revision activity, strong segmental performance and cost-control efforts make Apogee (APOG) stock a worthy investment option.

There were several double-digit boosts in December, with Mastercard and Eli Lilly leading the way with 16% and 15% increases, respectively. Abbott Labs began its second half-century of dividend growth

Apogee's (APOG) Q3 results reflect strong margin performance in the Architectural Framing Systems and Glass segments, offset by lower profitability in Architectural Services.